Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
Tepper, Ping G., Mardekian, Jack, Masseria, Cristina, Phatak, Hemant, Kamble, Shital, Abdulsattar, Younos, Petkun, William, Lip, Gregory Y. H., Garcia de Frutos, PabloТом:
13
Мова:
english
Журнал:
PLOS ONE
DOI:
10.1371/journal.pone.0205989
Date:
November, 2018
Файл:
PDF, 1000 KB
english, 2018
File converter
Більше результатів пошуку
More benefits 
